Wyrick Susan D. 4
4 · Sana Biotechnology, Inc. · Filed Mar 6, 2026
Research Summary
AI-generated summary of this filing
Sana (SANA) SVP Susan Wyrick Receives Stock Award & Option
What Happened Susan D. Wyrick, Senior Vice President, Finance and Accounting and Principal Accounting Officer at Sana Biotechnology (SANA), was awarded two equity grants on 2026-03-05: 206,250 restricted stock units (RSUs) and 45,833 stock option-type awards. Both grants were reported as derivative awards at $0.00 per share (no cash paid). Together these awards represent the contingent right to receive up to 252,083 shares of SANA common stock if vesting conditions are met.
Key Details
- Transaction date: 2026-03-05; Form 4 filed 2026-03-06 (timely filing).
- Award amounts: 206,250 RSUs and 45,833 option-style awards; reported price $0.00 (grant/award).
- Vesting: RSUs vest in four equal installments on March 5 of 2027, 2028, 2029 and 2030; the option-style award vests 25% on March 5, 2027 and then in 36 equal monthly installments thereafter (contingent on continued service).
- Shares owned after transaction: not specified in the provided excerpt.
- Filing remarks: reported role — SVP, Finance and Accounting and Principal Accounting Officer.
- No indication of a 10b5-1 plan, sale, purchase, tax withholding or cashless exercise in the provided filing excerpt.
Context
- RSUs are contingent rights to receive shares upon vesting; they are compensation, not an immediate stock purchase or sale.
- The option-style award vests over time and must typically be exercised (if applicable) before any shares are received; nothing in this filing indicates any immediate sale of shares.
- Such grants are routine for executive compensation and do not by themselves indicate a buy or sell market signal; they reflect future potential dilution if vested and settled.
Insider Transaction Report
Form 4
Wyrick Susan D.
See Remarks
Transactions
- Award
Restricted Stock Units
[F1][F2]2026-03-05+45,833→ 45,833 total→ Common Stock (45,833 underlying) - Award
Stock Option (Right to Buy)
[F3]2026-03-05+206,250→ 206,250 totalExercise: $3.41Exp: 2036-03-04→ Common Stock (206,250 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of Sana Biotechnology, Inc. ("Sana") common stock.
- [F2]The restricted stock units vest in four equal installments on each of March 5, 2027, 2028, 2029 and 2030, provided that the reporting person provides continuous service to Sana as an employee, consultant, director or officer of Sana through each such date.
- [F3]The option vests and becomes exercisable as to 25% of the underlying shares on March 5, 2027 and in 36 equal monthly installments thereafter, provided that the reporting person provides continuous service to Sana as an employee, consultant, director or officer of Sana through each such date.
Signature
/s/ Aaron M. Grossman, Attorney-in-Fact for Susan D. Wyrick|2026-03-06